Brian Short

Advises on nonclinical strategies to rapidly move biopharmaceuticals, small molecules, and medical devices from discovery and early development to market, including global development plans, nonclinical study design, and interacting with regulatory agencies and scientific advisers. Key competencies include: -Nonclinical drug and device development strategy and guidance -Ocular, dermal, and neurologic expertise -Toxicology program design and monitoring -Pathology peer reviews -Regulatory submissions and interactions -Due diligence reviews -Nonclinical model design for local delivery therapies

Atheln helps clients create and execute integrated pharma and biotech product development and commercialization strategies. Their global team of over 100 highly specialized, industry-seasoned experts excel at risk identification and mitigation, while delivering phase appropriate and customized solutions that increase value and likelihood of success.

Provide strategic oversight on all nonclinical safety programs supporting global clinical development and registration of biologic and small molecule pharmaceutical candidates. Nonclinical leader for several ocular biologics including nonclinical support up to global product registration. Facilitate cross-disciplinary interactions to ensure scientific integration in presentations, reports and regulatory and clinical documents.

Head of Pathology, with scientific and administrative leadership of pathologists and GLP Histology, Immunohistochemistry, and Clinical Pathology laboratories to support early discovery to global clinical development and registration of biologic and small molecule pharmaceutical candidates. Nonclinical leader and project team pathologist for several ocular biologics and small molecules.

Head of Toxicology, with scientific and administrative leadership of toxicologists and In Vivo Toxicology, Safety Pharmacology, Clinical Pathology, and Cellular and Genetic Toxicology GLP laboratories to support early discovery to global clinical development and registration of biologic and small molecule pharmaceutical candidates.

Project team toxicologist and pathologist responsible for the design, implementation and interpretation of nonclinical toxicology programs supporting global clinical development and registration of biologic and small molecule pharmaceutical candidates.